Please login to the form below

Not currently logged in


This page shows the latest sitagliptin news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk’s type 2 diabetes drug approved by FDA as first-line option

Novo Nordisk’s type 2 diabetes drug approved by FDA as first-line option

In the programme, Rybelsus was shown to more effectively lower blood sugar than sitagliptin and empagliflozin, and treatment with Rybelsus also resulted in up to 4.4kg reduction in body weight.

Latest news

More from news
Approximately 8 fully matching, plus 89 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts


Add my company
Fishawack Health

Established in 2001, Fishawack Health (FH) is a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries....

Latest intelligence

Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...